
    
      The drug being tested in this study is called azilsartan medoxomil (EdarbiÂ®). Azilsartan
      medoxomil is being tested to treat people who have hypertension. This study looks at the
      clinic systolic and diastolic blood pressure (SBP, DBP) in obese participants who were
      prescribed azilsartan medoxomil by physicians.

      The study enrolled 1945 patients. All participants were asked to take azilsartan medoxomil as
      prescribed by their physician according to local SmPC.

      This multi-center trial was conducted in the Russian Federation and the Republic of
      Kazakhstan. The overall duration of study for observation was approximately 6 months.
      Participants made multiple visits to the clinics as assigned by each physician according to
      their routine practice, in every 3 months.
    
  